Aviva’s Anterix ATEX Stock Holding History

Aviva’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-34,649	Closed	-$1.3M	–	943
2020 Q4	$1.3M	Sell	34,649 -28,088	-45%	-$926K	0.01%	817
2020 Q3	$2.05M	Buy	62,737 +11,357	+22%	+$481K	0.01%	777
2020 Q2	$2.33M	Sell	51,380 -34,510	-40%	-$1.76M	0.01%	646
2020 Q1	$3.92M	Buy	+85,890	New	+$3.89M	0.03%	467

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCC

Bain Capital Credit Boston, Massachusetts $303M AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

SSP

Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Aviva's ATEX Position: Q1 2021 in Review

Aviva sold out of Anterix (ATEX) in Q1 2021, closing a stake of 34,649 shares — an estimated $1.3M sold.

Aviva first reported a position in ATEX in Q1 2020 and held it in 4 quarters. The position peaked at $3.92M in Q1 2020. 97 funds tracked by Wall St. Rank hold ATEX as of Q1 2021.

Aviva reported no remaining Anterix position as of Q1 2021 after selling out during the quarter.
Aviva sold 34,649 Anterix shares in Q1 2021, an estimated $1.3M.
Aviva first reported a position in Anterix in Q1 2020 and held it in 4 quarters.
Aviva's Anterix position peaked at $3.92M in Q1 2020.
97 funds tracked by Wall St. Rank held Anterix as of Q1 2021.

Based on Aviva's 13F filing for Q1 2021, filed 13 May 2021.